ATE273295T1 - Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen - Google Patents

Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen

Info

Publication number
ATE273295T1
ATE273295T1 AT01918042T AT01918042T ATE273295T1 AT E273295 T1 ATE273295 T1 AT E273295T1 AT 01918042 T AT01918042 T AT 01918042T AT 01918042 T AT01918042 T AT 01918042T AT E273295 T1 ATE273295 T1 AT E273295T1
Authority
AT
Austria
Prior art keywords
producing
substituted
intermediate compounds
nicotine derivatives
compound
Prior art date
Application number
AT01918042T
Other languages
English (en)
Inventor
Anette Johansson
Torgny Svensson
Original Assignee
Independent Pharmaceutica Ab C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Independent Pharmaceutica Ab C filed Critical Independent Pharmaceutica Ab C
Application granted granted Critical
Publication of ATE273295T1 publication Critical patent/ATE273295T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AT01918042T 2000-03-21 2001-03-21 Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen ATE273295T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000933A SE0000933D0 (sv) 2000-03-21 2000-03-21 Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds
PCT/SE2001/000599 WO2001070730A1 (en) 2000-03-21 2001-03-21 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds

Publications (1)

Publication Number Publication Date
ATE273295T1 true ATE273295T1 (de) 2004-08-15

Family

ID=20278889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918042T ATE273295T1 (de) 2000-03-21 2001-03-21 Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen

Country Status (13)

Country Link
US (1) US6747156B2 (de)
EP (1) EP1265888B1 (de)
JP (1) JP4370073B2 (de)
AT (1) ATE273295T1 (de)
AU (2) AU4491301A (de)
CA (1) CA2402748C (de)
DE (1) DE60104825T2 (de)
ES (1) ES2225507T3 (de)
HK (1) HK1051854B (de)
PT (1) PT1265888E (de)
SE (1) SE0000933D0 (de)
TR (1) TR200402787T4 (de)
WO (1) WO2001070730A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005232129A (ja) * 2004-02-23 2005-09-02 Air Water Chemical Inc 芳香族性アセチレン類の製造方法
US9492400B2 (en) 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
WO2007070682A2 (en) 2005-12-15 2007-06-21 Massachusetts Institute Of Technology System for screening particles
CA2648099C (en) 2006-03-31 2012-05-29 The Brigham And Women's Hospital, Inc System for targeted delivery of therapeutic agents
EP2019691B1 (de) 2006-05-15 2020-08-12 Massachusetts Institute of Technology Polymere für funktionelle partikel
US9381477B2 (en) * 2006-06-23 2016-07-05 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
US20100144845A1 (en) * 2006-08-04 2010-06-10 Massachusetts Institute Of Technology Oligonucleotide systems for targeted intracellular delivery
WO2008124632A1 (en) * 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Amphiphilic compound assisted nanoparticles for targeted delivery
CA2917512C (en) 2007-10-12 2025-08-05 President And Fellows Of Harvard College VACCINE NANOTECHNOLOGY
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8343497B2 (en) * 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
CN102905728B (zh) 2010-05-26 2015-11-25 西莱克塔生物科技公司 具有不偶合的佐剂的纳米载体组合物
TWI578997B (zh) 2010-06-04 2017-04-21 輝瑞疫苗有限責任公司 用於預防或治療菸鹼成癮之共軛體
AU2014210682B2 (en) * 2010-06-04 2015-10-08 Pfizer Vaccines Llc Conjugates for the prevention or treatment of nicotine addiction
EP2640190A4 (de) 2010-11-05 2016-05-11 Selecta Biosciences Inc Modifizierte nikotinische verbindungen und zugehörige verfahren
US20130028857A1 (en) 2011-07-29 2013-01-31 Selecta Biosciences, Inc. Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents
US9303013B2 (en) 2014-05-16 2016-04-05 Pfizer Inc. Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4155909A (en) * 1977-06-13 1979-05-22 Philip Morris Incorporated 2-Alkyl nicotinoids and processes for their production
US4465833A (en) * 1980-10-15 1984-08-14 Hughes Aircraft Company Process for preparing ethynylated benzoic acid derivatives
DE4020053A1 (de) * 1990-01-31 1991-08-01 Bayer Ag Verfahren zur herstellung von 2-chlor-5-methyl-pyridin
DE4020052A1 (de) 1990-06-23 1992-01-02 Bayer Ag Verfahren zur herstellung von 2-chlor-5-methyl-pyridin
US5502194A (en) * 1992-02-19 1996-03-26 Bayer Aktiengesellschaft Process for the preparation of 2-halogeno-pyridine derivatives
KR100309871B1 (ko) 1999-02-24 2001-10-29 윤종용 (-)피리도벤즈옥사진 카르복실산 유도체의 제조방법
SE9801923D0 (sv) * 1998-05-29 1998-05-29 Independent Pharmaceutical Ab Nicotine vaccine
US20040079259A1 (en) 2002-10-29 2004-04-29 Felix Manig Method of manufacturing cementitious materials
FR2849657B1 (fr) 2003-01-03 2005-07-15 Arjo Wiggins Feuille possedant un aspect iridescent, et son procede de fabrication

Also Published As

Publication number Publication date
ES2225507T3 (es) 2005-03-16
HK1051854A1 (en) 2003-08-22
SE0000933D0 (sv) 2000-03-21
PT1265888E (pt) 2004-11-30
US6747156B2 (en) 2004-06-08
DE60104825T2 (de) 2005-09-29
EP1265888A1 (de) 2002-12-18
TR200402787T4 (tr) 2004-11-22
CA2402748C (en) 2010-02-16
EP1265888B1 (de) 2004-08-11
JP2003529568A (ja) 2003-10-07
DE60104825D1 (de) 2004-09-16
HK1051854B (en) 2005-02-18
AU2001244913B2 (en) 2005-08-11
AU4491301A (en) 2001-10-03
WO2001070730A1 (en) 2001-09-27
CA2402748A1 (en) 2001-09-27
US20030187270A1 (en) 2003-10-02
JP4370073B2 (ja) 2009-11-25

Similar Documents

Publication Publication Date Title
DE60104825D1 (de) Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen
DE60336867D1 (de) Verfahren zur Herstellung von 3-Halo-4,5-Dihydro-1H-Pyrazolen
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
MXPA04001323A (es) Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso.
DK1613304T3 (da) DPP-IV-inhibitorer
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
CY1110399T1 (el) Ρυθμιστες της τετραϋδροπυρανυλο κυκλοπεντυλο τετραϋδροπυριδοπυριδινης για την ενεργοτητα των υποδοχεων των χημειοκινων
DE60326819D1 (de) Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase
DE60001182D1 (de) Erythromycin-Derivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel
CY1105666T1 (el) Διεργασια για την παρασκευη αζακυκλοαλκανοϋλαμινοθειαζολων
DE60310609D1 (de) Verfahren zur herstellung von 2-aminomethylpyridin-derivaten
DE69920708D1 (de) Verfahren zur herstellung von 1,4-bis[[2-(dimethylamino)ethyl amino]-5,8-dihydroxyanthracene-9,10-dion
DE602005026827D1 (de) Verfahren zur herstellung von isoindolderivaten
ATE502030T1 (de) Imidazolderivate, verfahren zu deren herstellung und deren verwendung
ATE280769T1 (de) Verfahren zur herstellung von vitronectin- rezeptorantagonisten
PT1347960E (pt) Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina
DE60103752D1 (de) Verfahren zur herstellung von pyrazolopyridinderivaten
DE60335805D1 (de) Verfahren zur herstellung von 1,3-dioxolan-nucleosiden
HUP0104045A2 (hu) Eljárás 4-[(2',5'-diamino-6'-halogén-pirimidin-4'-il)-amino]-ciklopent-2-enilmetanol-származékok előállítására
DE60306361D1 (de) Verfahren zur herstellung von benazeprilhydrochloride
DE60236303D1 (de) Verfahren zur herstellung von 14-beta-hydroxybaccatin-iii-1,14-carbonat
BR0011559A (pt) Processo para a preparação de derivados de 10, 11-metano benzossuberano
DE69818431D1 (de) Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin
DE602004027401D1 (de) Verfahren zur herstellung von polymorphen von sertralin hydrochlorid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1265888

Country of ref document: EP